ELV · Elevance Health Inc. Common Stock
View on chartInsiders & Stakes
| Gail Boudreaux Director | ▲ Buy | Open Market | 171,976 Shares held | 7/17/2026 | View profile |
| John E. Gallina Director | ▼ Sell | Tax Withholding | 63,725 Shares held | 3/2/2023 | View profile |
| MCCARTHY GLORIA M EVP & Chief Administrative Off | ▼ Sell | Open Market | 51,435 Shares held | 3/24/2023 | View profile |
| Felicia F. Norwood Director | ▼ Sell | Tax Withholding | 38,838 Shares held | 3/3/2026 | View profile |
| Mark Kaye EVP & CFO | ▲ Buy | Grant | 30,503 Shares held | 10/2/2026 | View profile |
| Peter D. Haytaian EVP & Pres., DBG & IngenioRx | ▼ Sell | Tax Withholding | 27,222 Shares held | 3/3/2026 | View profile |
| Patel Prakash R EVP & President, DBG | ▼ Sell | Tax Withholding | 17,230 Shares held | 9/4/2021 | View profile |
| Ratnakar Lavu EVP & Chief Digital Officer | ▼ Sell | Tax Withholding | 16,149 Shares held | 3/3/2026 | View profile |
| Todt Blair Williams EVP and Chief Legal Officer | ▼ Sell | Tax Withholding | 15,631 Shares held | 1/3/2025 | View profile |
| STARK LEAH EVP & CHRO | ▼ Sell | Tax Withholding | 12,403 Shares held | 12/30/2021 | View profile |
| Lewis Hay III Director | ▲ Buy | Grant | 12,070 Shares held | 5/13/2026 | View profile |
| Charles Morgan Kendrick Jr. EVP & President, Commercial | ▼ Sell | Open Market | 11,791 Shares held | 3/6/2026 | View profile |
| Ramiro G. Peru Director | ▲ Buy | Open Market | 10,908 Shares held | 7/17/2026 | View profile |
| Robert L. Dixon Jr. Director | ▼ Sell | Open Market | 10,734 Shares held | 6/11/2026 | View profile |
| Elizabeth E. Tallett Director | ▲ Buy | Grant | 10,291 Shares held | 5/15/2024 | View profile |
| R. Kerry Clark Director | ▲ Buy | Grant | 9,640 Shares held | 5/14/2025 | View profile |
| Erin M. Wessling EVP & Chief Legal Officer | ▼ Sell | Tax Withholding | 7,230 Shares held | 9/3/2026 | View profile |
| Ryan M. Schneider Director | ▲ Buy | Grant | 7,163 Shares held | 5/13/2026 | View profile |
| Ryan R. Craig EVP & Chief HR Officer | ▼ Sell | Tax Withholding | 6,530 Shares held | 9/2/2026 | View profile |
| Antonio F. Neri President and CEO | ▲ Buy | Grant | 5,488 Shares held | 5/13/2026 | View profile |
| Bahija Jallal CHIEF EXECUTIVE OFFICER | ▲ Buy | Grant | 5,351 Shares held | 5/13/2026 | View profile |
| Alter Jeffrey D. EVP, IngenioRx & Anthem Health | ▼ Sell | Tax Withholding | 5,107 Shares held | 10/1/2021 | View profile |
| Steven H. Collis Director | ▲ Buy | Grant | 4,202 Shares held | 5/13/2026 | View profile |
| Susan D. DeVore Director | ▲ Buy | Grant | 4,065 Shares held | 5/13/2026 | View profile |
| Ronald W. Penczek SVP, Chief Accounting Officer | ▼ Sell | Open Market | 3,740 Shares held | 6/12/2026 | View profile |
| Deanna D. Strable-Soethout Chair, President and CEO | ▲ Buy | Grant | 2,209 Shares held | 5/13/2026 | View profile |
| Amy W. Schulman Director | ▲ Buy | Grant | 781 Shares held | 5/13/2026 | View profile |
Transaction History
| Mark Kaye | ▼ Sell | Tax Withholding | 4,161 | $1.6M | 10/2/2026 |
| Mark Kaye | ▲ Buy | Grant | 2,627 | $0 | 10/2/2026 |
| Erin M. Wessling | ▼ Sell | Tax Withholding | 255 | $106K | 9/3/2026 |
| Erin M. Wessling | ▼ Sell | Tax Withholding | 94 | $38K | 9/2/2026 |
| Ryan R. Craig | ▼ Sell | Tax Withholding | 144 | $58K | 9/2/2026 |
| Gail Boudreaux | ▲ Buy | Open Market | 680 | $249K | 7/17/2026 |
| Gail Boudreaux | ▲ Buy | Open Market | 2,045 | $753K | 7/17/2026 |
| Ramiro G. Peru | ▲ Buy | Open Market | 1,000 | $366K | 7/17/2026 |
| Ronald W. Penczek | ▼ Sell | Open Market | 369 | $149K | 6/12/2026 |
| Robert L. Dixon Jr. | ▼ Sell | Open Market | 151 | $61K | 6/11/2026 |
| Ronald W. Penczek | ▲ Buy | Option Exercise | 654 | $177K | 5/19/2026 |
| Ronald W. Penczek | ▲ Buy | Option Exercise | 877 | $273K | 5/19/2026 |
| Ronald W. Penczek | ▼ Sell | Open Market | 1,531 | $617K | 5/19/2026 |
| Ramiro G. Peru | ▲ Buy | Grant | 563 | $0 | 5/13/2026 |
| Bahija Jallal | ▲ Buy | Grant | 563 | $0 | 5/13/2026 |
| Ryan M. Schneider | ▲ Buy | Grant | 563 | $0 | 5/13/2026 |
| Amy W. Schulman | ▲ Buy | Grant | 563 | $0 | 5/13/2026 |
| Lewis Hay III | ▲ Buy | Grant | 563 | $0 | 5/13/2026 |
| Robert L. Dixon Jr. | ▲ Buy | Grant | 563 | $0 | 5/13/2026 |
| Susan D. DeVore | ▲ Buy | Grant | 563 | $0 | 5/13/2026 |
| Steven H. Collis | ▲ Buy | Grant | 563 | $0 | 5/13/2026 |
| Antonio F. Neri | ▲ Buy | Grant | 563 | $0 | 5/13/2026 |
| Deanna D. Strable-Soethout | ▲ Buy | Grant | 563 | $0 | 5/13/2026 |
| Amy W. Schulman | ▼ Sell | Open Market | 26 | $7K | 3/12/2026 |
| Charles Morgan Kendrick Jr. | ▼ Sell | Open Market | 3,196 | $911K | 3/6/2026 |
| Steven H. Collis | ▲ Buy | Open Market | 3,000 | $870K | 3/5/2026 |
| Ryan R. Craig | ▼ Sell | Tax Withholding | 309 | $88K | 3/3/2026 |
| Gail Boudreaux | ▼ Sell | Tax Withholding | 1,736 | $493K | 3/3/2026 |
| Ronald W. Penczek | ▼ Sell | Tax Withholding | 37 | $11K | 3/3/2026 |
| Erin M. Wessling | ▼ Sell | Tax Withholding | 417 | $118K | 3/3/2026 |
| Felicia F. Norwood | ▼ Sell | Tax Withholding | 496 | $141K | 3/3/2026 |
| Ratnakar Lavu | ▼ Sell | Tax Withholding | 222 | $63K | 3/3/2026 |
| Charles Morgan Kendrick Jr. | ▼ Sell | Tax Withholding | 467 | $133K | 3/3/2026 |
| Peter D. Haytaian | ▼ Sell | Tax Withholding | 446 | $127K | 3/3/2026 |
| Mark Kaye | ▼ Sell | Tax Withholding | 353 | $100K | 3/3/2026 |
| Felicia F. Norwood | ▲ Buy | Grant | 5,951 | $0 | 3/2/2026 |
| Ryan R. Craig | ▼ Sell | Tax Withholding | 25 | $7K | 3/2/2026 |
| Ryan R. Craig | ▲ Buy | Grant | 2,976 | $0 | 3/2/2026 |
| Felicia F. Norwood | ▼ Sell | Tax Withholding | 1,421 | $418K | 3/2/2026 |
| Ronald W. Penczek | ▲ Buy | Grant | 1,701 | $0 | 3/2/2026 |
| Ronald W. Penczek | ▲ Buy | Grant | 426 | $0 | 3/2/2026 |
| Ronald W. Penczek | ▼ Sell | Tax Withholding | 131 | $39K | 3/2/2026 |
| Ronald W. Penczek | ▲ Buy | Grant | 266 | $0 | 3/2/2026 |
| Gail Boudreaux | ▲ Buy | Grant | 16,153 | $0 | 3/2/2026 |
| Gail Boudreaux | ▲ Buy | Grant | 10,527 | $0 | 3/2/2026 |
| Erin M. Wessling | ▲ Buy | Grant | 2,976 | $0 | 3/2/2026 |
| Felicia F. Norwood | ▲ Buy | Grant | 2,865 | $0 | 3/2/2026 |
| Ratnakar Lavu | ▼ Sell | Tax Withholding | 315 | $93K | 3/2/2026 |
| Ratnakar Lavu | ▲ Buy | Grant | 5,101 | $0 | 3/2/2026 |
| Ratnakar Lavu | ▲ Buy | Grant | 6,802 | $0 | 3/2/2026 |
| Charles Morgan Kendrick Jr. | ▼ Sell | Tax Withholding | 1,211 | $356K | 3/2/2026 |
| Charles Morgan Kendrick Jr. | ▲ Buy | Grant | 4,017 | $0 | 3/2/2026 |
| Charles Morgan Kendrick Jr. | ▲ Buy | Grant | 2,532 | $0 | 3/2/2026 |
| Peter D. Haytaian | ▼ Sell | Tax Withholding | 1,201 | $353K | 3/2/2026 |
| Peter D. Haytaian | ▲ Buy | Grant | 2,865 | $0 | 3/2/2026 |
| Mark Kaye | ▼ Sell | Tax Withholding | 271 | $80K | 3/2/2026 |
| Mark Kaye | ▲ Buy | Grant | 6,377 | $0 | 3/2/2026 |
| Mark Kaye | ▲ Buy | Grant | 10,202 | $0 | 3/2/2026 |
| Gail Boudreaux | ▼ Sell | Tax Withholding | 6,713 | $2.0M | 3/2/2026 |
| Amy W. Schulman | ▲ Buy | Grant | 218 | $0 | 2/2/2026 |
| Ryan R. Craig | ▼ Sell | Tax Withholding | 279 | $95K | 2/2/2026 |
| Mark Kaye | ▼ Sell | Tax Withholding | 2,895 | $985K | 10/2/2025 |
| Erin M. Wessling | ▼ Sell | Tax Withholding | 152 | $49K | 9/3/2025 |
| Erin M. Wessling | ▲ Buy | Grant | 931 | $0 | 9/2/2025 |
| Ryan R. Craig | ▲ Buy | Grant | 970 | $0 | 9/2/2025 |
| Susan D. DeVore | ▲ Buy | Open Market | 1,200 | $375K | 8/19/2025 |
| Steven H. Collis | ▲ Buy | Grant | 639 | $0 | 8/1/2025 |
| Gail Boudreaux | ▲ Buy | Open Market | 2,334 | $668K | 7/18/2025 |
| Gail Boudreaux | ▲ Buy | Open Market | 5,116 | $1.5M | 7/18/2025 |
| Gail Boudreaux | ▲ Buy | Open Market | 1,050 | $302K | 7/18/2025 |
| Deanna D. Strable-Soethout | ▲ Buy | Grant | 601 | $0 | 5/14/2025 |
| Ryan M. Schneider | ▲ Buy | Grant | 601 | $0 | 5/14/2025 |
| Ramiro G. Peru | ▲ Buy | Grant | 601 | $0 | 5/14/2025 |
| Antonio F. Neri | ▲ Buy | Grant | 601 | $0 | 5/14/2025 |
| Robert L. Dixon Jr. | ▲ Buy | Grant | 601 | $0 | 5/14/2025 |
| R. Kerry Clark | ▲ Buy | Grant | 601 | $0 | 5/14/2025 |
| Susan D. DeVore | ▲ Buy | Grant | 601 | $0 | 5/14/2025 |
| Lewis Hay III | ▲ Buy | Grant | 601 | $0 | 5/14/2025 |
| Bahija Jallal | ▲ Buy | Grant | 601 | $0 | 5/14/2025 |
| Mark Kaye | ▼ Sell | Open Market | 4,588 | $1.9M | 4/24/2025 |
| Ronald W. Penczek | ▼ Sell | Open Market | 443 | $184K | 3/10/2025 |
| Charles Morgan Kendrick Jr. | ▼ Sell | Open Market | 3,504 | $1.4M | 3/5/2025 |
| Peter D. Haytaian | ▼ Sell | Tax Withholding | 2,281 | $902K | 3/3/2025 |
| Charles Morgan Kendrick Jr. | ▼ Sell | Tax Withholding | 2,221 | $878K | 3/3/2025 |
| Felicia F. Norwood | ▲ Buy | Grant | 4,213 | $0 | 3/3/2025 |
| Felicia F. Norwood | ▼ Sell | Tax Withholding | 2,613 | $1.0M | 3/3/2025 |
| Charles Morgan Kendrick Jr. | ▲ Buy | Grant | 3,686 | $0 | 3/3/2025 |
| Charles Morgan Kendrick Jr. | ▲ Buy | Grant | 2,845 | $0 | 3/3/2025 |
| Ronald W. Penczek | ▼ Sell | Tax Withholding | 198 | $78K | 3/3/2025 |
| Ronald W. Penczek | ▲ Buy | Grant | 421 | $0 | 3/3/2025 |
| Ratnakar Lavu | ▼ Sell | Tax Withholding | 312 | $123K | 3/3/2025 |
| Ratnakar Lavu | ▲ Buy | Grant | 2,339 | $0 | 3/3/2025 |
| Felicia F. Norwood | ▲ Buy | Grant | 3,035 | $0 | 3/3/2025 |
| Ronald W. Penczek | ▲ Buy | Grant | 285 | $0 | 3/3/2025 |
| Peter D. Haytaian | ▲ Buy | Grant | 3,035 | $0 | 3/3/2025 |
| Peter D. Haytaian | ▲ Buy | Grant | 4,213 | $0 | 3/3/2025 |
| Mark Kaye | ▼ Sell | Tax Withholding | 270 | $107K | 3/3/2025 |
| Mark Kaye | ▲ Buy | Grant | 3,604 | $0 | 3/3/2025 |
| Gail Boudreaux | ▼ Sell | Tax Withholding | 10,396 | $4.1M | 3/3/2025 |
| Gail Boudreaux | ▲ Buy | Grant | 10,620 | $0 | 3/3/2025 |
| Gail Boudreaux | ▲ Buy | Grant | 15,587 | $0 | 3/3/2025 |
| Todt Blair Williams | ▼ Sell | Tax Withholding | 398 | $148K | 1/3/2025 |
| Charles Morgan Kendrick Jr. | ▼ Sell | Tax Withholding | 846 | $350K | 11/1/2024 |
| Charles Morgan Kendrick Jr. | ▲ Buy | Grant | 1,710 | $0 | 11/1/2024 |
| Peter D. Haytaian | ▼ Sell | Tax Withholding | 1,649 | $683K | 11/1/2024 |
| Peter D. Haytaian | ▲ Buy | Grant | 3,799 | $0 | 11/1/2024 |
| Charles Morgan Kendrick Jr. | ▼ Sell | Open Market | 7,417 | $3.2M | 10/18/2024 |
| Mark Kaye | ▼ Sell | Tax Withholding | 2,818 | $1.4M | 10/2/2024 |
| Ramiro G. Peru | ▼ Sell | Open Market | 753 | $400K | 8/5/2024 |
| Gail Boudreaux | ▼ Sell | Open Market | 1,100 | $548K | 7/22/2024 |
| Gail Boudreaux | ▼ Sell | Open Market | 20,779 | $10.4M | 7/22/2024 |
| Gail Boudreaux | ▼ Sell | Open Market | 6,621 | $3.3M | 7/22/2024 |
| Gail Boudreaux | ▼ Sell | Open Market | 2,250 | $1.1M | 7/22/2024 |
| Gail Boudreaux | ▼ Sell | Open Market | 1,000 | $504K | 7/22/2024 |
| Gail Boudreaux | ▼ Sell | Open Market | 2,250 | $1.1M | 7/22/2024 |
| Robert L. Dixon Jr. | ▼ Sell | Open Market | 305 | $155K | 7/19/2024 |
| Deanna D. Strable-Soethout | ▲ Buy | Grant | 388 | $0 | 5/15/2024 |
| Bahija Jallal | ▲ Buy | Grant | 388 | $0 | 5/15/2024 |
| Lewis Hay III | ▲ Buy | Grant | 388 | $0 | 5/15/2024 |
| Robert L. Dixon Jr. | ▲ Buy | Grant | 388 | $0 | 5/15/2024 |
| Susan D. DeVore | ▲ Buy | Grant | 388 | $0 | 5/15/2024 |
| R. Kerry Clark | ▲ Buy | Grant | 388 | $0 | 5/15/2024 |
| Antonio F. Neri | ▲ Buy | Grant | 388 | $0 | 5/15/2024 |
| Ryan M. Schneider | ▲ Buy | Grant | 388 | $0 | 5/15/2024 |
| Ramiro G. Peru | ▲ Buy | Grant | 388 | $0 | 5/15/2024 |
| Elizabeth E. Tallett | ▲ Buy | Grant | 388 | $0 | 5/15/2024 |
| Felicia F. Norwood | ▼ Sell | Open Market | 3,434 | $1.8M | 4/24/2024 |
| Felicia F. Norwood | ▼ Sell | Open Market | 2,765 | $1.5M | 4/24/2024 |
| Felicia F. Norwood | ▲ Buy | Option Exercise | 2,043 | $487K | 4/24/2024 |
| Felicia F. Norwood | ▼ Sell | Open Market | 100 | $53K | 4/23/2024 |
| Felicia F. Norwood | ▲ Buy | Option Exercise | 5,473 | $1.3M | 4/23/2024 |
| Felicia F. Norwood | ▼ Sell | Open Market | 14,011 | $7.5M | 4/23/2024 |
| Charles Morgan Kendrick Jr. | ▼ Sell | Open Market | 2,432 | $1.2M | 3/8/2024 |
| Ronald W. Penczek | ▼ Sell | Open Market | 916 | $462K | 3/6/2024 |
| Peter D. Haytaian | ▲ Buy | Option Exercise | 15,000 | $2.5M | 3/4/2024 |
| Peter D. Haytaian | ▼ Sell | Open Market | 1,889 | $945K | 3/4/2024 |
| Peter D. Haytaian | ▼ Sell | Open Market | 15,000 | $7.5M | 3/4/2024 |
| Peter D. Haytaian | ▼ Sell | Open Market | 4,206 | $2.1M | 3/4/2024 |
| Ronald W. Penczek | ▼ Sell | Tax Withholding | 383 | $191K | 3/1/2024 |
| Todt Blair Williams | ▼ Sell | Tax Withholding | 3,650 | $1.8M | 3/1/2024 |
| Charles Morgan Kendrick Jr. | ▼ Sell | Tax Withholding | 1,484 | $741K | 3/1/2024 |
| Charles Morgan Kendrick Jr. | ▲ Buy | Grant | 2,354 | $0 | 3/1/2024 |
| Ratnakar Lavu | ▲ Buy | Grant | 1,754 | $0 | 3/1/2024 |
| Ronald W. Penczek | ▲ Buy | Grant | 226 | $0 | 3/1/2024 |
| Felicia F. Norwood | ▲ Buy | Grant | 9,152 | $0 | 3/1/2024 |
| Peter D. Haytaian | ▼ Sell | Tax Withholding | 4,314 | $2.2M | 3/1/2024 |
| Peter D. Haytaian | ▲ Buy | Grant | 2,405 | $0 | 3/1/2024 |
| Mark Kaye | ▲ Buy | Grant | 2,755 | $0 | 3/1/2024 |
| Gail Boudreaux | ▼ Sell | Tax Withholding | 19,256 | $9.6M | 3/1/2024 |
| Felicia F. Norwood | ▼ Sell | Tax Withholding | 4,902 | $2.4M | 3/1/2024 |
| Todt Blair Williams | ▲ Buy | Grant | 6,537 | $0 | 3/1/2024 |
| Ratnakar Lavu | ▲ Buy | Grant | 1,002 | $0 | 3/1/2024 |
| Todt Blair Williams | ▲ Buy | Grant | 2,154 | $0 | 3/1/2024 |
| Felicia F. Norwood | ▲ Buy | Grant | 2,405 | $0 | 3/1/2024 |
| Ronald W. Penczek | ▲ Buy | Grant | 1,046 | $0 | 3/1/2024 |
| Charles Morgan Kendrick Jr. | ▲ Buy | Grant | 2,154 | $0 | 3/1/2024 |
| Gail Boudreaux | ▲ Buy | Grant | 34,517 | $0 | 3/1/2024 |
| Peter D. Haytaian | ▲ Buy | Grant | 9,152 | $0 | 3/1/2024 |
| Gail Boudreaux | ▲ Buy | Grant | 8,415 | $0 | 3/1/2024 |
| Ramiro G. Peru | ▼ Sell | Open Market | 753 | $377K | 2/7/2024 |
| Todt Blair Williams | ▼ Sell | Tax Withholding | 397 | $191K | 1/3/2024 |
| Todt Blair Williams | ▲ Buy | Option Exercise | 5,492 | $1.7M | 12/14/2023 |
| Todt Blair Williams | ▼ Sell | Open Market | 5,492 | $2.7M | 12/14/2023 |
| Todt Blair Williams | ▼ Sell | Tax Withholding | 116 | $56K | 12/1/2023 |
| Todt Blair Williams | ▼ Sell | Tax Withholding | 1,127 | $544K | 12/1/2023 |
| Ronald W. Penczek | ▼ Sell | Open Market | 1,055 | $501K | 11/30/2023 |
| Peter D. Haytaian | ▼ Sell | Tax Withholding | 154 | $69K | 11/1/2023 |
| Charles Morgan Kendrick Jr. | ▼ Sell | Tax Withholding | 79 | $35K | 11/1/2023 |
| Ronald W. Penczek | ▼ Sell | Open Market | 64 | $29K | 10/24/2023 |
| Mark Kaye | ▲ Buy | Grant | 2,102 | $0 | 10/2/2023 |
| Mark Kaye | ▲ Buy | Grant | 18,174 | $0 | 10/2/2023 |
| Robert L. Dixon Jr. | ▼ Sell | Open Market | 310 | $148K | 7/21/2023 |
| Ramiro G. Peru | ▲ Buy | Grant | 457 | $0 | 5/10/2023 |
| Lewis Hay III | ▲ Buy | Grant | 457 | $0 | 5/10/2023 |
| Robert L. Dixon Jr. | ▲ Buy | Grant | 457 | $0 | 5/10/2023 |
| Antonio F. Neri | ▲ Buy | Grant | 457 | $0 | 5/10/2023 |
| Ryan M. Schneider | ▲ Buy | Grant | 457 | $0 | 5/10/2023 |
| Bahija Jallal | ▲ Buy | Grant | 457 | $0 | 5/10/2023 |
| Deanna D. Strable-Soethout | ▲ Buy | Grant | 457 | $0 | 5/10/2023 |
| R. Kerry Clark | ▲ Buy | Grant | 457 | $0 | 5/10/2023 |
| Susan D. DeVore | ▲ Buy | Grant | 457 | $0 | 5/10/2023 |
| Elizabeth E. Tallett | ▲ Buy | Grant | 457 | $0 | 5/10/2023 |
| MCCARTHY GLORIA M | ▼ Sell | Open Market | 3,000 | $1.3M | 3/24/2023 |
| MCCARTHY GLORIA M | ▼ Sell | Open Market | 600 | $264K | 3/24/2023 |
| MCCARTHY GLORIA M | ▼ Sell | Open Market | 500 | $221K | 3/24/2023 |
| MCCARTHY GLORIA M | ▼ Sell | Open Market | 5,573 | $2.5M | 3/24/2023 |
| MCCARTHY GLORIA M | ▼ Sell | Open Market | 1,800 | $798K | 3/24/2023 |
| MCCARTHY GLORIA M | ▼ Sell | Open Market | 3,625 | $1.6M | 3/24/2023 |
| Charles Morgan Kendrick Jr. | ▼ Sell | Open Market | 2,314 | $1.1M | 3/9/2023 |
| Ronald W. Penczek | ▼ Sell | Tax Withholding | 380 | $178K | 3/2/2023 |
| Felicia F. Norwood | ▼ Sell | Tax Withholding | 4,754 | $2.2M | 3/2/2023 |
| John E. Gallina | ▼ Sell | Tax Withholding | 4,650 | $2.2M | 3/2/2023 |
| MCCARTHY GLORIA M | ▼ Sell | Tax Withholding | 5,430 | $2.5M | 3/2/2023 |
| Peter D. Haytaian | ▼ Sell | Tax Withholding | 5,469 | $2.6M | 3/2/2023 |
| Gail Boudreaux | ▼ Sell | Tax Withholding | 17,614 | $8.3M | 3/2/2023 |
| Charles Morgan Kendrick Jr. | ▼ Sell | Tax Withholding | 1,084 | $508K | 3/2/2023 |
| Ronald W. Penczek | ▼ Sell | Tax Withholding | 64 | $30K | 3/1/2023 |
| Ronald W. Penczek | ▲ Buy | Grant | 1,195 | $0 | 3/1/2023 |
| Todt Blair Williams | ▼ Sell | Tax Withholding | 372 | $174K | 3/1/2023 |
| Todt Blair Williams | ▲ Buy | Grant | 2,133 | $0 | 3/1/2023 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Elevance Health Q3 Outlook: Premium Pressures and Sector Peer Trends
Elevance Health is preparing for its third-quarter earnings report, with analysts examining key metrics and the potential impact of lower premiums on the company's results. Broader sector news highlights peers like UnitedHealth, Centene, and Oscar Health pursuing growth and cost-saving strategies amidst shifting premium dynamics. The market is observing how these competitive and industry-wide pressures will align with Elevance Health's upcoming performance.
Elevance Health Q3 Outlook: Premium Pressures and Sector Peer Trends. Elevance Health is preparing for its third-quarter earnings report, with analysts examining key metrics and the potential impact of lower premiums on the company's results. Broader sector news highlights peers like UnitedHealth, Centene, and Oscar Health pursuing growth and cost-saving strategies amidst shifting premium dynamics. The market is observing how these competitive and industry-wide pressures will align with Elevance Health's upcoming performance.